Emblation

Emblation Limited is a private medical technology company based in Stirling, Scotland, founded in 2008. The company specializes in designing, manufacturing, and commercializing advanced microwave-based medical devices for treating various skin conditions and cancers. Established by microwave engineers Gary Beale and Eamon McErlean, Emblation aims to make microwave technology accessible to clinicians and patients across multiple medical fields. The company's core innovation is its microwave technology, which selectively destroys diseased tissue while preserving healthy tissue. This technology has applications in dermatology, podiatry, and oncology, with ongoing exploration in cardiology and gynecology. One of its notable products is Swift®, a treatment for warts and verrucas using microwave energy, launched in 2016. Emblation also offers a range of portable microwave generators for medical, industrial, scientific, and research applications. The company is dedicated to continuous research and development to enhance patient outcomes and expand the use of its technology globally.

• Employees 51
• Founded 2007
• Annual Revenue $3000000